Condition: The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease · Sponsor: Makerere University
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.
This description comes directly from the study's public registry record.
Radha Rajasingham, MD · 612 626-8171 · radha@umn.edu
Elizabeth Nalintya, MBChB,MPH · 0414307000 · nalintyaelizabeth@gmail.com
Always discuss trial participation with your own doctor first.
| kisugu health center IV | Kampala, Uganda | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05085171